日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Type I Interferon Drives a Cellular State Inert to TCR-Stimulation and Could Impede Effective T-Cell Differentiation in Cancer

I型干扰素驱动细胞进入对TCR刺激无反应的状态,并可能阻碍癌症中T细胞的有效分化。

Corvino, Dillon; Batstone, Martin; Hughes, Brett G M; Kempchen, Tim; Ng, Susanna S; Salim, Nazhifah; Schneppenheim, Franziska; Rommel, Denise; Kumar, Ananthi; Pearson, Sally; Madore, Jason; Koufariotis, Lambross T; Steinheuer, Lisa Maria; Pathirana, Dilan; Thurley, Kevin; Hölzel, Michael; Borcherding, Nicholas; Braun, Matthias; Bald, Tobias

CD96 Is an Immune Checkpoint That Regulates CD8(+) T-cell Antitumor Function.

CD96 是一种免疫检查点,可调节 CD8(+) T 细胞的抗肿瘤功能

Mittal Deepak, Lepletier Ailin, Madore Jason, Aguilera Amelia Roman, Stannard Kimberley, Blake Stephen J, Whitehall Vicki L J, Liu Cheng, Bettington Mark L, Takeda Kazuyoshi, Long Georgina V, Scolyer Richard A, Lan Ruth, Siemers Nathan, Korman Alan, Teng Michele W L, Johnston Robert J, Dougall William C, Smyth Mark J

Integrated molecular and immunophenotypic analysis of NK cells in anti-PD-1 treated metastatic melanoma patients

对接受抗PD-1治疗的转移性黑色素瘤患者的NK细胞进行整合分子和免疫表型分析

Lee, Hansol; Quek, Camelia; Silva, Ines; Tasker, Annie; Batten, Marcel; Rizos, Helen; Lim, Su Yin; Nur Gide, Tuba; Shang, Ping; Attrill, Grace H; Madore, Jason; Edwards, Jarem; Carlino, Matteo S; Guminski, Alexander; Saw, Robyn P M; Thompson, John F; Ferguson, Peter M; Palendira, Umaimainthan; Menzies, Alexander M; Long, Georgina V; Scolyer, Richard A; Wilmott, James S

Timing of neoadjuvant immunotherapy in relation to surgery is crucial for outcome

新辅助免疫疗法与手术的时机关系对预后至关重要。

Liu, Jing; O'Donnell, Jake S; Yan, Juming; Madore, Jason; Allen, Stacey; Smyth, Mark J; Teng, Michele W L

Author Correction: RGS7 is recurrently mutated in melanoma and promotes migration and invasion of human cancer cells

作者更正:RGS7在黑色素瘤中反复发生突变,并促进人类癌细胞的迁移和侵袭。

Qutob, Nouar; Masuho, Ikuo; Alon, Michal; Emmanuel, Rafi; Cohen, Isadora; Di Pizio, Antonella; Madore, Jason; Elkahloun, Abdel; Ziv, Tamar; Levy, Ronen; Gartner, Jared J; Hill, Victoria K; Lin, Jimmy C; Hevroni, Yael; Greenberg, Polina; Brodezki, Alexandra; Rosenberg, Steven A; Kosloff, Mickey; Hayward, Nicholas K; Admon, Arie; Niv, Masha Y; Scolyer, Richard A; Martemyanov, Kirill A; Samuels, Yardena

Immune correlates of metastatic melanoma patients treated with ipilimumab in combination with fotemustine in the phase II NIBIT-M1 study

在 II 期 NIBIT-M1 研究中,接受伊匹木单抗联合福莫司汀治疗的转移性黑色素瘤患者的免疫相关性

Sieh, Weiva; Köbel, Martin; Longacre, Teri A; Bowtell, David D; deFazio, Anna; Goodman, Marc T; Høgdall, Estrid; Deen, Suha; Wentzensen, Nicolas; Moysich, Kirsten B; Brenton, James D; Clarke, Blaise A; Menon, Usha; Gilks, C Blake; Kim, Andre; Madore, Jason; Fereday, Sian; George, Joshy; Galletta, Laura; Lurie, Galina; Wilkens, Lynne R; Carney, Michael E; Thompson, Pamela J; Matsuno, Rayna K; Kjær, Susanne Krüger; Jensen, Allan; Høgdall, Claus; Kalli, Kimberly R; Fridley, Brooke L; Keeney, Gary L; Vierkant, Robert A; Cunningham, Julie M; Brinton, Louise A; Yang, Hannah P; Sherman, Mark E; García-Closas, Montserrat; Lissowska, Jolanta; Odunsi, Kunle; Morrison, Carl; Lele, Shashikant; Bshara, Wiam; Sucheston, Lara; Jimenez-Linan, Mercedes; Driver, Kristy; Alsop, Jennifer; Mack, Marie; McGuire, Valerie; Rothstein, Joseph H; Rosen, Barry P; Bernardini, Marcus Q; Mackay, Helen; Oza, Amit; Wozniak, Eva L; Benjamin, Elizabeth; Gentry-Maharaj, Aleksandra; Gayther, Simon A; Tinker, Anna V; Prentice, Leah M; Chow, Christine; Anglesio, Michael S; Johnatty, Sharon E; Chenevix-Trench, Georgia; Whittemore, Alice S; Pharoah, Paul D P; Goode, Ellen L; Huntsman, David G; Ramus, Susan J; Maccalli, Cristina; Nicolay, Hugues; Capocefalo, Filippo; Fonsatti, Ester; Chiarucci, Carla; Cutaia, Ornella; Giannarelli, Diana; Parmiani, Giorgio; Di Giacomo, Anna Maria; Maio, Michele

Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.

Crk衔接蛋白是乳腺肿瘤发生过程中的关键信号整合因子

Fathers Kelly E, Bell Emily S, Rajadurai Charles V, Cory Sean, Zhao Hong, Mourskaia Anna, Zuo Dongmei, Madore Jason, Monast Anie, Mes-Masson Anne-Marie, Grosset Andree-Anne, Gaboury Louis, Hallet Michael, Siegel Peter, Park Morag

The genomic landscape of TP53 and p53 annotated high grade ovarian serous carcinomas from a defined founder population associated with patient outcome

TP53 和 p53 的基因组图谱注释了特定创始人群中与患者预后相关的高级别卵巢浆液性癌。

Wojnarowicz, Paulina M; Oros, Kathleen Klein; Quinn, Michael C J; Arcand, Suzanna L; Gambaro, Karen; Madore, Jason; Birch, Ashley H; de Ladurantaye, Manon; Rahimi, Kurosh; Provencher, Diane M; Mes-Masson, Anne-Marie; Greenwood, Celia M T; Tonin, Patricia N

H3K27 demethylation by JMJD3 at a poised enhancer of anti-apoptotic gene BCL2 determines ERα ligand dependency

JMJD3 对抗凋亡基因 BCL2 的激活增强子上的 H3K27 进行去甲基化,决定了其对 ERα 配体的依赖性。

Svotelis, Amy; Bianco, Stéphanie; Madore, Jason; Huppé, Gabrielle; Nordell-Markovits, Alexei; Mes-Masson, Anne-Marie; Gévry, Nicolas

Role of Pirh2 in mediating the regulation of p53 and c-Myc

Pirh2在介导p53和c-Myc调控中的作用

Hakem, Anne; Bohgaki, Miyuki; Lemmers, Bénédicte; Tai, Elisabeth; Salmena, Leonardo; Matysiak-Zablocki, Elzbieta; Jung, Yong-Sam; Karaskova, Jana; Kaustov, Lilia; Duan, Shili; Madore, Jason; Boutros, Paul; Sheng, Yi; Chesi, Marta; Bergsagel, P Leif; Perez-Ordonez, Bayardo; Mes-Masson, Anne-Marie; Penn, Linda; Squire, Jeremy; Chen, Xinbin; Jurisica, Igor; Arrowsmith, Cheryl; Sanchez, Otto; Benchimol, Samuel; Hakem, Razqallah